For following the competition: what moved in each program, several studies read as one move.
- inpegsomatropin
- peginterferon alfa-2b
- ACT201
- + 4 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Xiamen Amoytop Biotech to watchlistEvery Monday by email · turn it off any timePro · free during the beta